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Summary 
In dividing eukaryotic cells, nucleoli disperse before mitosis and reform in daughter cells at sites 
of ribosomal RNA (rRNA) gene clusters that are at the secondary constrictions of chromosomes, 
called nucleolus organizer regions (NORs). In this study, cDNA clones for a NOR autoantigen 
(NOR-90) were selected using a specific human autoantibody probe and were subsequently identified 
to encode an alternative form of the reported human upstream binding factor (hUBF). Results 
from  immunoprecipitation  showed  that  anti-NOR-90  antibodies  recognized  both  forms  of 
hUBF/NOR-90. Our data therefore showed that UBF, a critical factor in the regulation of rRNA 
transcription, was tightly bound to NOR during mitosis even when rRNA synthesis was thought 
to be minimal.  Furthermore,  we identified a nucleolar transcription  factor as a novel target for 
human  autoimmune  response. 
N 
'ucleolus organizer regions (NORs) 1 are the initiation 
sites for nucleologenesis where prenucleolar bodies con- 
verge and fuse to form interphasic nucleoli (1, 2). rRNA syn- 
thesis is integrally linked to active NORs (3). The number 
of NOKs varies among species and in cultured cell lines. There 
is a single NOR located on the X chromosome of the PtK2 
cell of rat kangaroos, while there are five NORs located on 
the acrocentric arms of chromosomes 13, 14, 15, 21, and 22 
in humans. Several nonhistone proteins are present at NOKs. 
These include RNA polymerase I, the enzyme essential for 
rRNA synthesis (4, 5), DNA topoisomerase I, which is im- 
portant  in transcription  and DNA replication  (6), and the 
nucleolar U3-RNP protein fibrillarin (2), recently shown to 
be required for pre-rRNA processing (7, 8). In 1987,  using 
autoantibodies from several patients  with  the systemic au- 
toimmune disease scleroderma, Rodriguez-Sanchez et al. (9) 
described a novel 90-kD nucleolar protein (NOR-90)  that 
is exclusively localized to  NOgs  in  dividing  cells and  to 
nucleoli in interphase.  Interestingly, scleroderma patients also 
make  autoantibodies  to  RNA  polymerase  I  (5),  DNA 
Topoisomerase I (10),  and fibrillarin (11). In this study, our 
initial objective was to characterize  the NOR-90 autoantigen. 
Our approach was to obtain cDNA clones for this nucleolar 
protein using the human  autoantibody probe. 
Abbreviation used in this paper: NOR, nucleosus organizer region. 
Materials and Methods 
Antibody andlmmunoblo#ing.  Human anti-NOR sera were col- 
lected over the last 2 yr at the W.M. Keck Autoimmune  Disease 
Center Laboratory serum bank. Anti-NOR-90 seraJO and SC were 
kindly provided by Professor M. J. Fritzler,  (University  of Cal- 
gary, Alberta, Canada). Reference anti-NOR-90 serum CAG from 
the original study was also obtained from Dr. C. Gelpi (Santa Cruz 
y San Pablo Hospital, Barcelona, Spain) (9). MOLT-4 cell extracts 
were prepared and separated on SDS-PAGE using a 20-cm 15% 
separating gel and analyzed by immunoblotting using sera diluted 
1:100 and nSI-protein A (ICN Biochemicals, Irvine, CA) as de- 
tecting reagent  (12). Affinity-purified antibodies to recombinant 
phage plaques were prepared by incubating diluted serum ST with 
recombinant phage protein bound to nitrocellulose filters and sub- 
sequently eluted at pH 2.3 as described (12). 
Immunofluorescence.  HEp-2 cells were cultured  in DMEM as 
described (13), grown on coverslips, fiaed for 20 rain at room tem- 
perature  in 2% formaldehyde buffered with PBS, and permeabi- 
lived with 100% acetone at - 20"C. Human sera were used at 1:100 
dilution.  Fluorescein-conjusated  goat anti-human  IgG was used 
as secondary detecting reagent. For chromosomal spreads, male In- 
dian muntjac  cells (cell line CCL 157), cultured  in HAM's F-10 
medium,  were treated with Colcemid (0.01 #g/ml) for 6 h, and 
mitotic cells were processed for immunofluorescence (14). Before 
mounting,  chromosomes were counter-stained with ethidium bro- 
mide (1/~g/ml).  Silver staining for NOgs was performed as de- 
scribed (15). 
cDNA Cloning and Sequence Analysis.  Human serum ST was 
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Xgt11 cDNA library (16). Two clones, J1 and J3, were selected and 
cDNAs were subcloned into the EcoRI site of pBluescript SK- 
(Stratagene,  La Jolla,  CA).  A  HepG2 cell  ~Eap cDNA library 
(gift from Dr.  Frank R. Jirik,  University of British Columbia) 
was  screened  for full-length  NOR-90  cDNA  clones  by DNA 
hybridization  using  two  overlapping complementary  synthetic 
oligonucleotides (5'-TGGCCCGATTCAGGGAGGATCACCCC- 
GACC-3'  and  5'-TGGCATTCTGGATTAGGTCGGGGTGAT- 
CCT-Y) designed from the 5' sequence  of the J3 cDNA.  These 
primers were mixed and labeled with [32p]ATP  using the standard 
fill-in  reaction of Klenow polymerase (17).  Clones NOR2  and 
NOR5 were selected and subcloned in vivo into pBluescript plasmid 
using  R408  helper phage (Stratagene),  as recommended in  the 
manufacturer's instructions. Plasmids were purified and DNA se- 
quences in both strands were determined (18, 19). DNA and pro- 
tein sequences  were analyzed by the Genetics Computer Group 
Sequence Analysis Software Package for VAX computers (20). Align- 
ment of protein sequences was initially achieved with the GAP pro- 
gram that used the algorithm of  Needleman and Wunsch (21). Mul- 
tiple  sequence  alignments  were  performed  with  CLUSTAL 
programs (22,  23). 
ImmunofrecipitationofRecombinantandCellularProducts.  Plasmid 
clone NOR5 and a hUBF cDNA plasmid pTj~GUBF1, which was 
kindly provided by Drs.  H.-M. Jantzen and R. Tjian (24),  were 
used as DNA templates.  RNA was transcribed in vitro from lin- 
earized plasmids using T3 or T7 RNA polymerase and was trans- 
lated  in  vitro  in  a  rabbit  reticulocyte lysate  (Promega  Biotec, 
Madison,  WI) in the presence  of [3SS]methionine (Tran3SS-label; 
ICN Biochemicals), as described in the manufacturer's  instructions. 
These labeled in vitro products were used as substrates  in an im- 
munoprecipitation  assay (13). HeLa ceils were cultured as monolayers 
and labeled with [sSS]methionine as described (13). Labeled HeLa 
cells were harvested by lysis in buffer A (150 mM NaC1,  10 mM 
Tris-HC1, pH 7.5, 0.5% NP-40) on ice and centrifuged at 10,000 
g for 10 min. The nuclear pellet was sonicated in 0.1% SDS, 0.5% 
NP-40, 0.1% deoxycholic acid, 50 mM Tris-HC1, pH 7.5, by three 
10-s bursts. The resuhing nuclear supernatant was used as substrate 
in immunoprecipitation assay and analyzed by SDS-PAGE using 
a  10%  separating gel (13). 
Figure 2.  Immunoblotting analysis of MOLT-4  cell extracts. Lanes  1-4, 
human NOR-90 autoimmune sera ST, II, JO, and SC; lane 5, a normal 
human serum; lane 6, affinity-purified  antibodies from XJ3 plaques reacted 
with serum ST showing the reactivities  with the 90-kD proteins and the 
58- and 62-kD bands; lane 7, whole serum ST control. Note the a~nity- 
purified antibody preparation no longer recognized the 52-kD SS-A/Ro 
protein (lane 6). 
Results and Discussion 
The anti-NOR-90 sera used in this study gave strong NOR 
immunofluorescence in dividing HEp-2 cells, and, in inter- 
phasic nucleoli, discrete speckles were seen resembling nu- 
cleolar fibrillar centers that are active in rDNA transcription 
(Fig. 1 a). The immunofluorescence staining of NORs could 
be particularly well demonstrated in male Indian muntjac cells 
that have a diploid chromosome number of 7 (25) with two 
NORs  located on  the X  and  Y1  chromosomes  (Fig.  1  b). 
Figure 1.  Immunolocalization  of NOR- 
90 proteins. (a) HEp-2 cells were stained 
with human NOR-90 serum II showing 
NOR fluorescence  (arrowheads) in dividing 
cells. Note the multiple discrete speckles 
in interphase nucleoli (arrows).  (b)  Chro- 
mosomal spreads of Indian muntjac cells 
reacted with  serum  II  to  show NOR 
staining (arrowheads). Chromosomal stain- 
ing observed was produced by ethidium 
bromide  counterstaining.  (c) The same sub- 
strate in b was later processed with the 
NOR silver staining method to visualize 
NORs (arrowheads). (d) The NORs (arrow- 
heads)  of Indian muntjac  chromosomal 
spreads were stained  by affinity-purified  an- 
tibody to the recombinant protein derived 
from the  NOR5  clone. (e) HEp-2 cells 
showing  discrete speckles in  interphase 
nucleoli  were stained  with affinity-purified 
antibodies to the recombinant fusion pro- 
tein encoded by the kJ3 clone (x 160). 
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-120  ~  ---i~~ii~T~A~ 
1HN  G  E  A  D  C  P  T  D  L  E  M  A  A  P  K  G  O  D  R  W  8  0  E  D  M  L  T  L  L  E  C  H  K  N  N  L  P  S 
121  AAT~TCACACATOGACTGGGAAAAA~r~TTTA~  iii i~  I'G~q~qCATO'rGcAAGCTCAAATGOGTO~AGATTTCT.4A'/'GA~GT~ 
41  N  D  S  S  K  F  K  T  T  E  S  B  t4  D  W  g  K  V  A  F  K  D  Y  S  G  D  14  C  It  L  K  W  V  Z  !  S  JJ  s.  V  R 
241  AAGTTCCGTACATTG.qC~GAATTGATCCTCGA~TGTTAAAAATCCTT~T(XEAAAOAAGCCCCTGACCCCTTATTTC 
01  K  F  R  T  L  T  E  L  1  L  D  A  Q  E  U  V  K  M  P  Y  K  ￿9  K  K  L  K  K  H  P  D  F  P  K  v  p  L  T  P  Y  F 
361  CGCTTCT  TCAT~TAT~TCCA~T~AACCT~A~TTCTGTCCA~T~T~ 
121  R  F  Fd'M  E  K  R  A  K  Y  A  K  L  H  P  g  H  8  N  L  D  L  T  K  I  L  S  K  K  Y  Ic  Z  L  P  Z  K  K  K  M  K 
481  TATAT~~T~TOOCCCC~T~~&ATCCAGAA~TCGGACA~ 
& 
181  u  I  Q  D  F  Q  R  E  K  OAE  F  Z  R  N  L  A  R  F  R  E  D  8  P  D  L  I  Q  m  A  K  K  S  D  I  P  E  K  P  K 
801  ACCCCCCAGCAGC  TGI"GGT~TA  TC  TCAAAGTGCG(X:C,  AGATGAGATCATGAGAGAC  TATA~  TCAGTGAGGAGGG  TA  TC 
K 
201  T  P  Q  Q  L  W  Y  T  H  E  K  K  V  Y  L  K  V  R  P  D4  Lie  I  H  R  D  Y  I  Q  K  n  P  E  L  N  I  S  I~  E  G  I 
721  ACCAAGTCCACCC~TTTP~0C~q~CC~  ~ACTCGCTGT~T(R~CCA.qCATGAAG 
241T  K  8  T  L  T  K  A  E  R  0  L  K  D  K  F  D  G  R  P  T  K  P  P  P  N  S  Y  S  L  Y  C  A  g  L  HA  Nt4K 
841  GACGT~  TOG'FGC  T  ~  TCC~  TA'/~'/~TCA~4A~T  TACGAGG  TGGAG 
281  D  V  P  S  T  Ir  R  M  V  L  C  S  O  O  W  K  L  L  S  O  K  g  K  D  A  Y  H  K  W  C  D  O  K  K  K  D  u  g  V  E 
861  CTGC~TCT~TGCIT,  AAC.A~ 
321  L  L  R  F  L  E  8  L  P  ~'  E  E  Q  Q  R  V  L  G  E  E  K  M  L  N  I  N  K  K  Q  A  T  S  P  A  S  K  K  P  A  Q 
1081  - - ~~ATGTTC.,ATCTTC  ....  ~r~~ 
381  E  G  (}  K  G  G  S  E  K  P  K  R  P  V  S  A  M  F  1  F  S  E  E  K  R  R  O  L  Q  1[  E  R  P  E  L  8  g  S  E  L 
1201  ~TGGCCCGAATGTGGAACGACCTGTC~AAGTACAJtGGCCC~AA 
401  T  R  L  L  A  R  H  W  N  D  L  S  E  K  K  K  A  K  Y  K  A  R  E  A  A  L  K  A  Q  S  E  R  K  P  G  G  E  R  E  I~ 
1321  C~  .~TC~T~TC~TATC~ACCT~TTCAAG.qA'~T~TG 
441  R  G  K  L  P  E  S  P  K  R  A  E  E  I  W  Q  Q  S  V  I  G  D  u  L  A  R  F  K  N  D  R  V  K  A  L  tc  A  M  E  H 
1441  .qCCTOGAATAACAT~T~TT~~TA~TGAGTGAGATG~ACAAATTCT 
461  T  14  N  N  g  E  K  K  E  K  L  M  W  I  K  K  A  A  E  D  Q  K  R  Y  E  R  E  L  S  E  M  R  A  P  P  A  A  T  N  S 
1561 TCC~TGAAA~TCCCATGA/~CGGTTAC~TTCTCCC~'/~TCCAA'~  AT~ 
521 S  K  K  M  K  F  Q  G  E  P  K  K  P  P  M  N  G  Y  Q  K  F  S  Q  E  L  L  S  N  G  E  L  N  H  L  P  L  K  E  R  M 
1681  ~C~TC~TACAAAAAGC~  - -~x~TTAAD-.ld~OCCTG 
581 Y  E  I  G  S  R  W  Q  R  I  S  Q  S  (}  K  E  H  Y  g  K  L  A  E  E  0  (}  K  0  Y  K  V  H  L  D  L  W  V  K  S  L 
1801  TCTCCC~T~TATAAA~ACATCTCCAATAAACGTAAGAGCAT(~T~TCC~A~TCC~ 
801 S  P  Q  D  R  A  A  Y  K  g  Y  I  S  N  K  R  K  S  M  T  K  L  R  G  P  N  P  K  S  S  R  T  T  L  Q  S  K  S  ~  S 
1921  ~TGA~TGA6~A~TGAAGAAGAGGAAGA  T~A  TC,  AGAATGGGGAC  TCCTCTC~ ~ 
641 E  Z  D  D  ~  E  D  1~  D  D  E  D  E  D  E  E  E  E  D  D  E  N  O  D  S  8  E  D  ￿9  G  D  8  S  E  S  8  S  E  p  l~ 
2041  AGC~TG~TGAGAAT~~TGACGATC~TGAAGATAATGAG  - - ZC.C  i~,r~, ~'*.S~  ZCAGGGGAC 
681 5  E  D  G  D  E  N  E  E  D  D  E  D  Z  D  D  D  E  D  D  D  E  D  Z  D  N  E  S  E  G  8  S  S  S  8  S  8  S  G  D 
2161  ~~TCCCCAAC'/'GACCACC~  ~ ~TT~~ 
721  S  8  D  $  D  S  N  *  7~7 
r(*.)  2310;  3'-ersd  of N(~.5 
J 
2281  CC~I'TTAAAAAAAAAAATAC~A~  TCT~TCA~ 
2~01  CCAGGGACAGCAACTATCAG/~T~TTCT~CACTTOC~I~GACAA~ 
2521 AGAGT~CC~~TCCA~TTG(~TTCC~i~;~;ACCT~TT~AG 
2641  ~q.qC.A~  ~  TC  TCCCC  ~  ~.~AG~qG~%~C  TG(  JCT(gGRCCCGT  TCA~ 
2761  GI'~'~'~ATATATGTGTATATATTTTTTTTA.qC~,~@A~.~G~C~tC~ACGTTTCCTACCG'(A  n )  2828;  3'-end  of  J3 
3"UT  Jl: 
2311  ~~TG~~TOCCTCGT~CCACCTCATGCTTATAAT~TCAGAGACI:C.,C  T 
2431  GCTT~CTC-(A  n)  2488;  3'-end  of  ,11 
Figure  3.  The  complete nucleo- 
tide/protein sequence  (NOR5/J3 com- 
bined) and the 3'UT sequence in J1 
shown here have been submitted to 
EMBL/Genbank  under  accession 
numbers X56687 and X56688, respec- 
tively. The  5'  UT  sequence, which 
differed  from that ofhUBF,  an in-frame 
stop codon in the 5'UT, an AATAAA 
polyadenylation signal sequence  in the 
YUT of  J1, and the COOH-terminal 
acidic region are underlined. Two ar- 
rowheads indicate the Y-start of clone 
J1 and J3, respectively.  The sequence  of 
the four independent NOR. cDNAs all 
lack 111 nucleotides reported in hUBF 
(24). The arrow indicates the site of the 
deletion of 111 nucleotides (37 amino 
acids), which is present in hUBF. 
The location of NORs was confirmed by silver staining (Fig. 
1 c).  Fig.  2 shows the immunoblotting  analysis  of human 
NOR-90 sera. All NOR-90 sera showed common reactivity 
to two bands in the 90-kD region and to other bands at 58 
and 62 kD. This separation of NOR-90 into a doublet is ap- 
parent  (Fig.  2; reference 26), although  this was not clearly 
resolved in the earlier report (9). The 58- and 62-kD species 
were probably degradation products of the 90-kD proteins 
since they were also recognized by affinity-purified antibodies 
(see below). Furthermore,  the relative intensity of reactivity 
within these bands was constant over a 250-fold dilution range 
of serum. Autoantibody titers were generally very high; NOR- 
90 bands were detectable with  1:25,000 dilution  of serum 
JO. The four human anti-NOR-90  sera did not have other 
detectable autoantibody speciificities, except serum ST, which 
had autoantibodies to the 52-kD SS-A/Ro protein autoan- 
tigen  (12)  (Fig.  2,  lanes  i  and  7). 
Serum ST was used to screen a MOLT-4 cell Xgt11 library, 
and two cDNA clones, XJ1 (2 kb) and hJ3 (2.3 kb), were 
isolated.  To show that these clones encoded the NOR-90 pro- 
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teins, antibodies were affinity purified from serum ST using 
recombinant plaques bound on nitrocellulose.  Affinity-purified 
antibodies to ~,J1 or XJ3 plaques reacted with NORs (Fig. 
1 d) and demonstrated expected patterns of speckled staining 
in interphasic nucleoli (Fig.  1 e). The same affinity-purified 
antibody was specific for NOR-90 proteins in immunoblot- 
ting (Fig.  2, lane 6). The nucleotide sequences of J1 and J3 
were identical, except at the Y-untranslated  (3'UT) regions 
(Fig.  3). 
Northern blot analysis of cellular mRNA showed that J1 
and J3 cDNA inserts detected a major band at "~3 kb and 
a minor band of higher M,, and were therefore too small to 
encode the complete mRNA.  Two clones, NOR5 (2.5 kb) 
and NOR2 (1.2 kb), were further  selected from a HepG2 
cell cDNA library using 5' oligonudeotide probes from J3 
cDNA.  Although  the 3' UT region was mostly absent in 
clone NOR5  (Fig.  3),  sequence analysis  of NOR5 cDNA 
showed an open reading frame spanning  727 amino  acids, 
and the predicted protein had a pI of 5.3 (20) and a molecular 
mass of 84,842 dahons. In vitro transcription and translation Figure  4.  Immunoprecipitation  analysis.  (A)  The  [3sS]methionine- 
labeled in vitro translation products of NOR5 were tested for reactivity 
with human sera. Lane I, normal human serum;  lanes 2-5, human anti- 
NOR.-90 sera ST, II, JO, and SC, respectively. (B) Comigration of NOR- 
90 proteins with NOR5  and hUBF in vitro translation products. Lane 
1,  14C-labeled molecular mass markers  (New England Nuclear, Boston, 
MA). Lane 2, immunoprecipitation of 3SS-labeled  HeLa cell extracts with 
serum JO. Lanes 3 and 4, 3sS-labeled  in vitro translation products derived 
from NOR.5  eDNA before and after immunoprecipitation with serum 
JO, respectively. Lanes 5 and 6, 3SS-labeled  in vitro translation products 
derived from hUBF cDNA plasmid pTBGUBF1 before and after immu- 
noprecipitation with serum JO. Lanes 7, 8, and 9, the immunoprecipita- 
tion of an equal mixture of the labeled in vitro translation products of 
hUBF and NOR5 using serum JO, affinity-purified  antibody from XJ3 
plaques,  and a normal human serum, respectively. 
of NOR5 cDNA yielded a 90-kD protein recognized by all 
anti-NOR-90  sera (Fig.  4 A). 
Homology search in the GenBank/NBRF database showed 
that the NOR protein sequence was identical with that of 
rRNA transcription factor hUBF (24), with the exception 
that the published hUBF sequence had an additional 37-amino 
acid insert (Fig. 3). Since rRNA accounts for '~80% of total 
cellular RNA, the genes for this important kNA species have 
been studied extensively (for review see reference 27). Efficient 
rRNA transcription requires the presence of RNA polymerase 
I complex and at least two auxiliary factors,  SL1 and UBF 
(28).  hUBF is known to bind to an upstream control ele- 
ment (-200  to  -107)  and a core element (-45  to 20) of 
rlLNA genes (29, 30). Footprinting data suggest that hSL1 
and hUBF form a protein-protein complex that interacts with 
a critical region of the upstream regulatory sequence (31). 
The formation of the hSLI-hUBF complex is essential for 
the activation of rRNA transcription, and the upstream control 
element is known to enhance the transcriptional activity of 
RNA polymerase I by 10-100-fold  (24). 
Purified cellular hUBF was reported to consist of two poly- 
peptides of 94 and 97 kD (31). Direct comparison of the in 
vitro transcription and translation products of NOR-90 and 
hUBF  cDNAs  (24)  showed that  the product  of NOR5 
comigrated with the lower band of the NOR-90 doublet while 
the product of hUBF had the same gel mobility as the upper 
band of the NOIL-90 doublet (Fig. 4 B). The recombinant 
hUBF protein was also immunoprecipitated  by the NOR-90 
human autoantibodies. Further proof that NOR-90 and hUBF 
are identical was provided by affinity-purified antibodies from 
XJ3 plaques, which recognized both proteins (Fig. 4 B, lane 8). 
Southern blot analysis of human PBL genomic DNA sug- 
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gested only one gene for NOR-90 cDNA (data not shown 
and reference 24). Therefore, we propose that the two pro- 
teins are derived from a common precursor hUBF mRNA 
via alternative splicing (Fig. 5 a). The analysis of hUBF pro- 
tein sequence revealed motifs (HMG box) that were similar 
to the high mobility group (HMG-1) nonhistone  chromosomal 
proteins (24). When UBF was used as the prototype HMG 
box protein, several  interesting members of this DNA binding 
protein family were described (see reference 32). Our sequence 
alignment analysis showed that there were six HMG boxes 
in the high Mr form of hUBF, while in the low Mr form, 
the central 37 amino acid residues of the second HMG box 
(II) were absent (Fig. 5 b). Comparison of the six HMG boxes 
showed that HMG boxes I, II, and III had the highest degree 
of similarity to boxes IV, V, and VI, respectively (Fig. 5 c). 
In the earlier study (24), boxes V and VI were not described 
but they actually have higher percent identity values (26.6% 
and 27.1%) to human HMG protein than boxes II and III 
(21.2% and 21.7%; Fig. 5 c). A recent report in the Xenopus 
UBF sequence also suggested that there were two extra un- 
reported HMG boxes (V and VI) in the hUBF sequence (33). 
Since Jantzen et al. (24) showed that the recombinant frag- 
ment containing residues 1-204, including HMG box I, was 
as efficient in DNA binding as the full-length hUBF mole- 
cule, the alternative form described here might be expected 
to  recognize and bind to  the  UBF  recognition sequence 
efficiently. 
Jantzen et al. (34) reported a single HeLa cDNA that in- 
cluded HMG box II, while we obtained from two cDNA 
libraries four independent cDNA clones all lacking the 37- 
residue sequence. The two forms of UBF have been detected 
in several species,  including rat and frog (34, 35). The NOR-90 
doublet was also detected in approximately equal intensities 
in HeLa,  MOLT-4,  and rat Novikoff hepatoma whole cell 
extracts by immunoblotting (data not shown). Our cloning 
of the low Mr hUBF form was in complete agreement with 
a recent report by O'Mahony and Rothblum (36), who de- 
scribed a similar 37-amino acid in-frame deletion in the low 
Me form of rat UBF. 
Secondary constrictions are normally identified as achro- 
matic regions on prophase or metaphase chromosomes that 
are stained with dyes such as Giemsa. However, electron mi- 
croscopic examination of achromatic regions shows no real 
constriction of the chromosome since the measured widths 
are the same at the secondary constrictions and other regions 
of chromosome arms  (37,  38).  Therefore,  the metaphase 
NOR, although described as a secondary constriction, may 
actually not be a tightly condensed region of chromosomes 
(37, 38). The immunolocalization of RNA polymerase I (5) 
and hUBF to NORs during mitosis suggests that these cru- 
cial proteins are probably never completely disengaged from 
rDNA even when rRNA  synthesis  is minimal. 
Human serum autoantibodies from patients with systemic 
autoimmune diseases have been invaluable research tools for 
many studies in cellular and molecular biology (39). Although 
the mechanism for the production of these autoantibodies 
is still unclear,  the striking feature is that these antibodies 
inhibit the functions of their respective target antigens in most 
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IV  i00  18.9  20.0  30.5 
V  i00  17.9  26.6 
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Figure  5.  Features  of  NOR-90/ 
hUBE (a) Diagrammatic summary of 
NOR-90/hUBF proteins. The protein 
sequence of NOR5 is identical with 
that of hUBF except for a deletion of 
37 amino acids starting at residue 221. 
The proposed scheme of alternative 
splicing may explain the rehtionship of 
the two forms of NOR-90/hUBF pro- 
teins. The HMG boxes marked with an 
asterisk  were previously defined in 
hUBF (24). Boxes  V and VI are defined 
based on the amino acid  sequence  align- 
ment shown in b comparing  hUBF and 
human HMG-1 sequences (hHMG). 
HMG boxes I, II, and III are aligned 
adjacent to boxes IV, V, and VI, respec- 
tivdy, in order to show their respectivdy 
closer relationships. Filled and  open 
circles highlight the identical amino add 
residues and conserved  substitutions be- 
tween the subgroups: boxes I, IV; II, 
V; III, VI. Conserved  or identical amino 
acids in four or more of  the seven listed 
sequences are boxed. Conserved  amino 
acids are grouped as foUows:  (K,R,H), 
(E,D,Q,N), (ST), (F,Y~V), (G,A,P), and 
(M,L,V,I). Sequence in hUBF HMG 
box II that is absent in the NOR5 pro- 
tein sequence is double underlined. (c) 
The percent identity derived from the 
GAP program is listed for comparison 
among  the  HMG  boxes of hUBF. 
HMG boxes I, II, and III show the 
highest degree of identity to boxes IV, 
V, and VI, respectively. 
functional assays (39). Therefore, our description of antibody 
to a RNA polymerase I transcription factor may provide new 
tools for the functional study ofrDNA gene regulation. The 
definition of NOR-90 antigen as an accessory factor in RNA 
polymerase I  transcription  also adds  to our understanding 
of the molecular structure  and  function of autoantigens. 
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